Message Font: Serif | Sans-Serif
 
No. of Recommendations: 1
you have triewd for years to tell us how MAKO is the next ISRG

You obviously have me confused with someone else ... or, as was the case, you are just making things up to suit your preconceptions.

Go ahead and find the data yourself since you question it.

I think the burden is on you to find relevant data. Comparing the two at the present time is clearly inappropriate, so to make a contention that there is even a difference, we need relevant data.

Of course, one doesn't know the future of MAKO ... otherwise investing would be a lot easier ... but that doesn't keep one from putting academic or general adoption curves side by side and comparing adoption from date of release. And, as I said, one should look at the whole curve since it may be that ISRG had some early advantage because of the ED issue that would not carry over into later indications.

The point is that you are making assertions of how poorly MAKO has done in comparison and are providing no relevant data to support that assertion. Seems likely, even, that MAKO is not being adopted as quickly, but that doesn't make them a failure.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement